主动脉瓣狭窄

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e72-227.全文

National Institute for Health and Care Excellence. Heart valve disease presenting in adults: investigation and management. Nov 2021 [internet publication].全文

Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632.全文  摘要

1. European Society of Cardiology. Epidemiology of aortic valve stenosis (AS) and of aortic valve incompetence (AI): is the prevalence of AS/AI similar in different parts of the world?. Feb 2020 [internet publication].全文

2. Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013 Sep 10;62(11):1002-12.全文  摘要

3. Strange GA, Stewart S, Curzen N, et al. Uncovering the treatable burden of severe aortic stenosis in the UK. Open Heart. 2022 Jan;9(1):e001783.全文  摘要

4. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023 Feb 21;147(8):e93-621.全文  摘要

5. Coffey S, Cox B, Williams MJ. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol. 2014 Jul 1;63(25 pt a):2852-61.全文  摘要

6. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005 Jun 21;111(24):3316-26.全文  摘要

7. Lewin MB, Otto CM. The bicuspid aortic valve: adverse outcomes from infancy to old age. Circulation. 2005 Feb 22;111(7):832-4.全文  摘要

8. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003 Jul;24(13):1231-43.全文  摘要

9. Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013 Feb 7;368(6):503-12.全文  摘要

10. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997 Mar 1;29(3):630-4. 摘要

11. Rattazzi M, Bertacco E, Del Vecchio A, et al. Aortic valve calcification in chronic kidney disease. Nephrol Dial Transplant. 2013 Dec;28(12):2968-76.全文  摘要

12. Shroff GR, Bangalore S, Bhave NM, et al. Evaluation and management of aortic stenosis in Chronic Kidney Disease: a scientific statement from the American Heart Association. Circulation. 2021 Jun 22;143(25):e1088-114.全文  摘要

13. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1721-8.全文  摘要

14. Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. The Tromsø study. Heart. 2013 Mar;99(6):396-400.全文  摘要

15. Roberts WC, Ko JM. Valvular heart disease: Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005 Feb 22;111(7):920-5.全文  摘要

16. Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci. 2003 Apr;325(4):237-42. 摘要

17. Adabag AS, Dykoski R, Ward H, et al. Critical stenosis of aortic and mitral valves after mediastinal irradiation. Catheter Cardiovasc Interv. 2004 Oct;63(2):247-50. 摘要

18. Rosenhek R, Rader F, Loho N, et al. Valvular heart disease: Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004 Sep 7;110(10):1291-5.全文  摘要

19. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005 Jun 9;352(23):2389-97.全文  摘要

20. Yan AT, Koh M, Chan KK, et al. Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study. J Am Coll Cardiol. 2017 Mar 28;69(12):1523-32.全文  摘要

21. Ozumi K, Tasaki H, Yamashita K, et al. Valvular and supravalvular aortic stenosis in heterozygous familial hypercholesterolemia, a case report. J Atheroscler Thromb. 2005;12(5):289-93. 摘要

22. Nazarzadeh M, Pinho-Gomes AC, Smith Byrne K, et al. Systolic blood pressure and risk of valvular heart disease: a Mendelian randomization study. JAMA Cardiol. 2019 Aug 1;4(8):788-95.全文  摘要

23. Kontogeorgos S, Thunström E, Lappas G, et al. Cumulative incidence and predictors of acquired aortic stenosis in a large population of men followed for up to 43 years. BMC Cardiovasc Disord. 2022 Feb 13;22(1):43.全文  摘要

24. Martinsson A, Li X, Zöller B, et al. Familial aggregation of aortic valvular stenosis: a nationwide study of sibling risk. Circ Cardiovasc Genet. 2017 Dec;10(6):e001742.全文  摘要

25. Kaltoft M, Langsted A, Nordestgaard BG. Obesity as a causal risk factor for aortic valve stenosis. J Am Coll Cardiol. 2020 Jan 21;75(2):163-76.全文  摘要

26. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e72-227.全文

27. Lombard TJ, Selzer A. Valvular aortic stenosis. A clinical and hemodynamic profile of patients. Ann Intern Med. 1987 Feb;106(2):292-8. 摘要

28. National Institute for Health and Care Excellence. Heart valve disease presenting in adults: investigation and management. Nov 2021 [internet publication].全文

29. American College of Radiology. ACR appropriateness criteria: preprocedural planning for transcatheter aortic valve replacement. 2023 [internet publication].全文

30. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e35-71.全文  摘要

31. Balciunaite G, Skorniakov V, Rimkus A, et al. Prevalence and prognostic value of late gadolinium enhancement on CMR in aortic stenosis: meta-analysis. Eur Radiol. 2020 Jan;30(1):640-51. 摘要

32. Tarantini G, Tang G, Nai Fovino L, et al. Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC working group on cardiovascular surgery. EuroIntervention. 2023 May 15;19(1):37-52.全文  摘要

33. Ruile P, Blanke P, Krauss T, et al. Pre-procedural assessment of aortic annulus dimensions for transcatheter aortic valve replacement: comparison of a non-contrast 3D MRA protocol with contrast-enhanced cardiac dual-source CT angiography. Eur Heart J Cardiovasc Imaging. 2016 Apr;17(4):458-66.全文  摘要

34. Chaturvedi A, Hobbs SK, Ling FS, et al. MRI evaluation prior to Transcatheter Aortic Valve Implantation (TAVI): when to acquire and how to interpret. Insights Imaging. 2016 Apr;7(2):245-54.全文  摘要

35. Généreux P, Stone GW, O'Gara PT, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2016 May 17;67(19):2263-88.全文  摘要

36. Ennezat PV, Maréchaux S, Iung B, et al. Exercise testing and exercise stress echocardiography in asymptomatic aortic valve stenosis. Heart. 2009 Jun;95(11):877-84. 摘要

37. Picano E, Pibarot P, Lancellotti P, et al. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009 Dec 8;54(24):2251-60. 摘要

38. Maréchaux S, Hachicha Z, Bellouin A, et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J. 2010 Jun;31(11):1390-7.全文  摘要

39. Amato MC, Moffa PJ, Werner KE, et al. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart. 2001 Oct;86(4):381-6.全文  摘要

40. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005 Jul;26(13):1309-13.全文  摘要

41. Loscalzo J. From clinical observation to mechanism--Heyde's syndrome. N Engl J Med. 2012 Nov 15;367(20):1954-6. 摘要

42. Nishimura RA, Holmes DR Jr. Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med. 2004 Mar 25;350(13):1320-7. 摘要

43. Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound. J Am Soc Echocardiogr. 2009 Sep;22(9):975-1014.全文

44. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632.全文  摘要

45. National Institute for Health and Care Excellence. Transcatheter aortic valve implantation for aortic stenosis. Jul 2017 [internet publication].全文

46. Brown JM, O'Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009 Jan;137(1):82-90. 摘要

47. Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000 Oct;36(4):1152-8. 摘要

48. Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol. 2003 Mar 19;41(6):893-904. 摘要

49. Stassano P, Di Tommaso L, Monaco M, et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol. 2009 Nov 10;54(20):1862-8. 摘要

50. Lund O, Bland M. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg. 2006 Jul;132(1):20-6. 摘要

51. Kundi H, Strom JB, Valsdottir LR, et al. Trends in isolated surgical aortic valve replacement according to hospital-based transcatheter aortic valve replacement volumes. JACC Cardiovasc Interv. 2018 Nov 12;11(21):2148-56.全文  摘要

52. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 May 3;366(18):1686-95. 摘要

53. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2477-84. 摘要

54. Smith CR, Leon MB, Mack MJ, et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187-98. 摘要

55. Généreux P, Cohen DJ, Williams MR, et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014 Mar 25;63(11):1100-9. 摘要

56. Reynolds MR, Magnuson EA, Wang K, et al; PARTNER Trial Investigators. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial (Cohort A). J Am Coll Cardiol. 2012 Aug 7;60(6):548-58.全文  摘要

57. Hahn RT, Pibarot P, Stewart WJ, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol. 2013 Jun 25;61(25):2514-21. 摘要

58. Gleason TG, Reardon MJ, Popma JJ, et al. 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol. 2018 Dec 4;72(22):2687-96.全文  摘要

59. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012 Mar 27;59(13):1200-54.全文  摘要

60. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21;363(17):1597-607.全文  摘要

61. Kapadia SR, Tuzcu EM, Makkar RR, et al. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation. 2014 Oct 21;130(17):1483-92.全文  摘要

62. Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2485-91. 摘要

63. Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012 May 3;366(18):1696-704. 摘要

64. Reynolds MR, Magnuson EA, Lei Y, et al. Valvular heart disease: Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011 Nov 1;124(18):1964-72.全文  摘要

65. Leon MB, Smith CR, Mack MJ, et al; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016 Apr 28;374(17):1609-20.全文  摘要

66. Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020 Feb 27;382(9):799-809.全文  摘要

67. Reardon MJ, Van Mieghem NM, Popma JJ, et al; SURTAVI Investigators. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017 Apr 6;376(14):1321-31. 摘要

68. Siemieniuk RA, Agoritsas T, Manja V, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ. 2016 Sep 28;354:i5130.全文  摘要

69. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1695-705.全文  摘要

70. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1706-15.全文  摘要

71. Kolkailah AA, Doukky R, Pelletier MP, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Cochrane Database Syst Rev. 2019 Dec 20;12:CD013319.全文  摘要

72. Letac B, Cribier A, Eltchaninoff H, et al. Evaluation of restenosis after balloon dilatation in adult aortic stenosis by repeat catheterization. Am Heart J. 1991 Jul;122(1 Pt 1):55-60. 摘要

73. Rossebø AB, Pedersen TR, Boman K, et al; SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008 Sep 25;359(13):1343-56.全文  摘要

74. Chan KL, Teo K, Dumesnil JG, et al; ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010 Jan 19;121(2):306-14.全文  摘要

75. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105-1110.全文  摘要

76. Smith WT 4th, Ferguson TB Jr, Ryan T, et al. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol. 2004;44:1241-1247. 摘要

77. Pereira JJ, Balaban K, Lauer MS, et al. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. Am J Med. 2005;118:735-742. 摘要

78. Faggiano P, Ghizzoni G, Sorgato A, et al. Rate of progression of valvular aortic stenosis in adults. Am J Cardiol. 1992 Jul 15;70(2):229-33. 摘要

79. Sorgato A, Faggiano P, Aurigemma GP, et al. Ventricular arrhythmias in adult aortic stenosis: prevalence, mechanisms, and clinical relevance. Chest. 1998 Feb;113(2):482-91. 摘要

80. Kvidal P, Bergstrom R, Horte LG, et al. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000 Mar 1;35(3):747-56. 摘要

81. Ståhle E, Kvidal P, Nyström SO, et al. Long-term relative survival after primary heart valve replacement. Eur J Cardiothorac Surg. 1997 Jan;11(1):81-91. 摘要

82. Vaquette B, Corbineau H, Laurent M, et al. Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome. Heart. 2005 Oct;91(10):1324-9.全文  摘要

83. Sharma UC, Barenbrug P, Pokharel S, et al. Systematic review of the outcome of aortic valve replacement in patients with aortic stenosis. Ann Thorac Surg. 2004 Jul;78(1):90-5. 摘要

84. Pellikka PA, Sarano ME, Nishimura RA, et al. Valvular heart disease: Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005 Jun 21;111(24):3290-5.全文  摘要